Tetrahydrocannabinol

1. 2026-10-19issueIssued emergency
2. 2026-10-19issueIssued info_card
3. 2026-09-07srcTherapeutic Use of Cannabis and Cannabinoids: A Review.
4. 2026-09-07srcAcute Effects of Smoked and Vaporized Cannabis in Healthy Adults Who Infrequently Use Cannabis
5. 2026-09-07srcPharmacotherapies for cannabis use disorder.
6. 2026-09-07srcCannabis-based medicines for chronic neuropathic pain in adults
7. 2026-09-07srcCannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis.
8. 2026-09-07srcCannabis and anxiety: a critical review of the evidence
9. 2026-09-07srcMedical Cannabis: A plurimillennial history of an evergreen.
10. 2026-09-07srcDose-dependent effect of acute THC on extinction memory recall and fear renewal: a randomized, double-blind, placebo-controlled study.
11. 2026-09-07srcCannabis, cannabinoids and health: a review of evidence on risks and medical benefits.
12. 2026-09-07srcChemical diversity, receptor binding affinity, and pharmacology of phytocannabinoids: Insights into neuronal mechanisms.
13. 2026-09-07srcTargeting the Endocannabinoid System in the Treatment of Posttraumatic Stress Disorder: A Promising Case of Preclinical-Clinical Translation?
14. 2026-09-07srcThe differential effects of medicinal cannabis on mental health: A systematic review.
15. 2026-09-07srcThe contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study.
16. 2026-09-07srcIsolation, Structure, and Partial Synthesis of an Active Constituent of Hashish
17. 2026-09-07srcDelta9-Tetrahydrocannabinol Induces Dopamine Release in the Human Striatum
18. 2026-09-07srcUS Epidemiology of Cannabis Use and Associated Problems
19. 2026-09-07srcThe diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin
20. 2026-09-07srcThe Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for Psychosis
21. 2026-09-07srcHigh-Potency Marijuana Impairs Executive Function and Inhibitory Motor Control
22. 2026-09-07srcBlunted psychotomimetic and amnestic effects of delta-9-tetrahydrocannabinol in frequent users of cannabis.
23. 2026-09-07srcCannabinoid receptor localization in brain.
24. 2026-09-07srcThe failings of per se limits to detect cannabis-induced driving impairment: Results from a simulated driving study.
25. 2026-09-07srcChronic Adolescent Delta9-Tetrahydrocannabinol Treatment of Male Mice Leads to Long-Term Cognitive and Behavioral Dysfunction, Which Are Prevented by Concurrent Cannabidiol Treatment.
26. 2026-09-07srcAn Updated Analysis of Clinical Outcome Measures Across Patients From the UK Medical Cannabis Registry.
27. 2026-09-07srcCannabinoid Hyperemesis Syndrome: Reports of Fatal Cases.
28. 2026-09-07srcClinical management of cannabis withdrawal.
29. 2026-09-07srcRare but relevant: Cannabinoid hyperemesis syndrome.
30. 2026-09-07srcThe pharmacokinetics and the pharmacodynamics of cannabinoids
31. 2026-09-07srcExpression of Central and Peripheral Cannabinoid Receptors in Human Immune Tissues and Leukocyte Subpopulations
32. 2026-09-07srcRole of Endogenous Cannabinoids in Synaptic Signaling
33. 2026-09-07srcCharacterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study
34. 2026-09-07srcHigh Stakes: Exploring the Impact of Cannabis Use in Pregnancy and Lactation.
35. 2026-09-07srcThe cannabis withdrawal syndrome: current insights
36. 2026-09-07srcPharmacokinetics and Pharmacodynamics of Cannabinoids
37. 2026-09-07srcMarijuana Use and Its Impact on Outpatient Anesthesia.
38. 2026-09-07srcDrug Interactions of Tetrahydrocannabinol and Cannabidiol in Cannabinoid Drugs.
39. 2026-09-07srcCannabis sativa: The Plant of the Thousand and One Molecules
40. 2026-09-07srcCannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System
41. 2026-09-07srcCannabinoids: Therapeutic Use in Clinical Practice.
42. 2026-09-07srcCannabis use and its impact on respiratory physiology and lung cancer risk: Mechanistic and epidemiological insights.
43. 2026-09-07srcCannabis-Based Products for Chronic Pain: A Systematic Review.
44. 2026-09-07srcCardiovascular effects of prolonged delta-9-tetrahydrocannabinol ingestion.
45. 2026-09-07srcIsolation and structure of a brain constituent that binds to the cannabinoid receptor.
46. 2026-09-07srcHistory of cannabis and its preparations in saga, science, and sobriquet.
47. 2026-09-07srcCannabinoids in the treatment of chemotherapy-induced nausea and vomiting.
48. 2026-09-07srcDetermination and characterization of a cannabinoid receptor in rat brain.
49. 2026-09-07srcJustice Department Places FDA-Approved Marijuana Products in Schedule III (2026)
50. 2026-09-07srcCannabis Controlled Substances Act Schedule I Classification
51. 2026-09-07srcDEA Proposed Rule: Rescheduling Marijuana from Schedule I to Schedule III
52. 2026-09-04issueIssued emergency
53. 2026-09-04issueIssued info_card
54. 2026-09-04issueIssued notice
55. 2026-06-04proposal51 value proposals approved togetherone review action inferred from a shared reviewer and instant — the graph records one activity per proposal
56. 2026-06-04publicationPublication — backfill
57. 2026-05-07revisionRevision 1
58. 2026-05-07genGeneration — pipeline-v5 · with 1 morepipeline-v5
59. 2026-05-07rungeneration run

The same entries, as forms: six forms.